RCS - Intelligent Ultrasnd - NHS Scotland Adopts Classroom to Clinic Training

Intelligent UltrasoundAnnouncement

29/02/2024 07:15

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240229:nRSc8593Ea&default-theme=true

RNS Number : 8593E  Intelligent Ultrasound Group PLC  29 February 2024

Intelligent Ultrasound's NeedleTrainer and ScanNav Anatomy Peripheral Nerve
Block now part of NHS Scotland anaesthetist training program

 

PRESS RELEASE 29 February 2024: Intelligent Ultrasound Group plc (AIM: IUG),
the 'classroom to clinic' ultrasound company specialising in AI software and
simulation, is pleased to announce NHS Education for Scotland (NES) has
incorporated the company's NeedleTrainer and ScanNav Anatomy Peripheral Nerve
Block (PNB) in its anaesthesia training program.

 

Intelligent Ultrasound's Classroom to Clinic package is designed to meet the
two key challenges of ultrasound guided regional anaesthesia (UGRA): capturing
and interpreting ultrasound images and inserting the needle to deposit local
anaesthetic at a target site. The risks of poorly performed UGRA and
ultrasound-guided needle insertion are well documented, including damage to
nerves that can lead to chronic pain, loss of sensation and muscle weakness.
Poor identification of structures on ultrasound can lead to needle trauma to
blood vessels, the lung, bowel and kidney.

 

NeedleTrainer uses a retractable needle and virtual image overlays to simulate
needling non-invasively on a live participant, using an authentic live
ultrasound scan. This enables trainees to develop hand-eye coordination,
optimum positioning, and accuracy in ultrasound-guided interventional
procedures in a realistic clinical environment with minimal risk.

 

ScanNav Anatomy PNB produces a colour overlay on real-time ultrasound to
support scanning for UGRA. A recent study published in the British Journal of
Anaesthesia showed that availability of ScanNav Anatomy PNB was associated
with an increase in the number of blocks performed by anesthesiologists,
without a decrease in quality of care.

 

As a teaching package, this provides increased efficiency, whereby education
can be carried out in a cost-effective and scalable manner, with enhanced
educational outcomes. The platforms will be used at the School of Medicine,
University of St Andrews where Dr Alasdair Taylor and co-director Dr James
Bowness will use NeedleTrainer as part of their two-day Regional Anaesthesia:
Plan A Blocks course.

 

NES joins its counterpart body in Wales (Health Education and Improvement W
(https://www.intelligentultrasound.com/2022/04/25/heiw-invests-in-needletrainer/)
ales), which invested in Intelligent Ultrasound platforms to help meet
curriculum changes and provide more safe, effective learning opportunities in
ultrasound-guided interventional procedures.

 

Stuart Gall, Chief Executive Officer of Intelligent Ultrasound:
"Ultrasound-guided needle insertion is now a key competency requirement for
multiple specialties. This investment moves us closer to our vision of
transforming medical training, ensuring safer practices, and ultimately
enhancing patient care. Together, we are bridging the gap from classroom to
clinic with innovative solutions that empower medical professionals across
Scotland and beyond."

 

Dr Ed Mellanby, Simulation Associate Postgraduate Dean for Scotland, said: "It
is a huge challenge to consistently meet the requirements of training in
regional anaesthesia in a safe and reliable way across all trainees in
Scotland. We are developing a national approach to simulation training in
Scotland, with the aim of sharing resources and expertise across the country
in order to improve quality and equitability of access. This technology aligns
with that ambition and with both patient and curriculum requirements. I am
really excited to see how this can reduce the variability in practice and
training, and witness the positive impact on performance that we believe this
will produce."

 

Dr Alasdair Taylor, Consultant Anaesthetist, Ninewells Hospital, Dundee, said:
"As a team, we want to increase the delivery of safe and efficacious
ultrasound guided regional anaesthesia to patients in Scotland as the
potential benefits are well known. When performed well, patients benefit from
reduced morbidity, improved pain scores, and a reduced opiate requirement and
the consequent side effects. Organisations can benefit from greater theatre
efficiency, and shorter length and cost of inpatient stay. Also, with the
long-term aim of performing more awake regional anaesthesia, we can achieve a
reduced carbon footprint for surgical procedures."

 

 

ENDS

 

Enquiries:

 

 Intelligent Ultrasound Group plc   www.intelligentultrasound.com (http://www.intelligentultrasound.com)
 Stuart Gall, CEO                   Tel: +44 (0)29 2075 6534
 Helen Jones, CFO

 Cavendish Capital Markets Limited

 (Nominated advisor and broker)
 Giles Balleny (Corporate Finance)  Tel: +44 (0)20 7397 8900

 Nigel Birks (ECM)

 Dale Bellis (Sales)

 

  TB Cardew - PR Advisors   Intelligentultrasound@tbcardew.com (mailto:Intelligentultrasound@tbcardew.com)

  Ed Orlebar                          Tel: +44 (0)7738 724630
  Allison Connolly                                                    Tel: +44 (0)7587 453955
  Emma Pascoe-Watson                                                  Tel: +44 (0)7774 620415
  Jessica Pilling                                                     Tel: +44 (0)7918 584573

 

This is an RNS Reach announcement and the information contained is not
considered to have a significant impact on management's expectations of the
Group's performance. RNS Reach is an investor communication service aimed at
assisting listed and unlisted (including AIM quoted) companies to distribute
non-regulatory news releases into the public domain. Information required to
be notified under the AIM Rules for Companies, Market Abuse Regulation or
other regulation would be disseminated as an RNS regulatory announcement and
not on RNS Reach.

 

About Intelligent Ultrasound Group

Intelligent Ultrasound (AIM: IUG) is one of the world's leading 'classroom to
clinic' ultrasound companies, specialising in real-time hi-fidelity virtual
reality simulation for the ultrasound training market ('classroom') and
artificial intelligence-based clinical image analysis software tools for the
diagnostic medical ultrasound market ('clinic'). Based in Cardiff in
the UK and Atlanta in the US, the Group has two revenue streams:

 

Simulation

Real-time hi-fidelity ultrasound education and training through simulation.
Our main products are the ScanTrainer obstetrics and gynaecology training
simulator, the HeartWorks echocardiography training simulator,
the BodyWorks Eve Point of Care and Emergency Medicine training simulator
with Covid-19 module and the new BabyWorks Neonate and Paediatric training
simulator. To date over 1,700 simulators have been sold to over 800 medical
institutions around the world.

 

Clinical AI software

Deep learning-based algorithms to make ultrasound machines smarter and more
accessible using our proprietary ScanNav ultrasound image analysis technology.
Current products on the market utilising this technology are GE
HealthCare's SonoLyst software that is incorporated in their Voluson Expert
and SWIFT ultrasound machines; ScanNav Anatomy PNB that simplifies
ultrasound-guided needling by providing the user with real-time AI-based
anatomy highlighting for a range of medical procedures; and NeedleTrainer
that teaches real-time ultrasound-guided needling and incorporates ScanNav
Anatomy PNB.

 

www.intelligentultrasound.com (http://www.intelligentultrasound.com/)

 

NOTE: ScanNav Anatomy PNB is CE approved and cleared for sale in the US by the
FDA but is not available for sale in any other territory requiring government
approval for this type of product.

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAPPUCUPUPCGRR